CLNN Insider Trading (Clene)
Insider Ownership Percentage: 21.20%
Insider Buying (Last 12 Months): $1,999,996.92
Insider Selling (Last 12 Months): $0.00
Clene Insider Trading History Chart
Clene Share Price & Price History
$10.79
As of 06/22/2021 02:47 PM ET
Peter Thiel Bets Big On "Mushroom Boom."
From Investing Trends | Ad
LSD and "Mushroom stocks" are being listed on the NASDAQ and a recent breakthrough makes top investors VERY excited about the coming "Mushroom Boom."
Click Here To Read The Full Story
Clene Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/24/2021 | David J. Matlin | Director | Buy | 207,684 | $9.63 | $1,999,996.92 | 32,393 |  |
SEC Filings (Institutional Ownership Changes) for Clene (NASDAQ:CLNN)
4.15% of Clene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.
Institutional Buying and Selling by Quarter
Clene Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 5/19/2021 | Squarepoint Ops LLC | 30,676 | $0.39M | 0.0% | N/A | 0.051% |  |
| 5/18/2021 | Millennium Management LLC | 130,068 | $1.66M | 0.0% | N/A | 0.218% | |
| 5/18/2021 | Morgan Stanley | 2,105 | $27K | 0.0% | +110.5% | 0.004% | |
| 5/18/2021 | Citadel Advisors LLC | 46,163 | $0.59M | 0.0% | N/A | 0.077% | |
| 5/17/2021 | Ikarian Capital LLC | 118,533 | $1.52M | 0.1% | N/A | 0.199% | |
| 5/17/2021 | Goldman Sachs Group Inc. | 13,593 | $0.17M | 0.0% | N/A | 0.023% | |
| 5/13/2021 | Laird Norton Trust Company LLC | 249,561 | $3.19M | 0.4% | N/A | 0.419% | |
| 5/13/2021 | Penserra Capital Management LLC | 5,840 | $74K | 0.0% | N/A | 0.010% | |
| 5/13/2021 | Kepos Capital LP | 200,000 | $2.56M | 0.2% | -24.0% | 0.336% | |
| 5/13/2021 | Citigroup Inc. | 10,646 | $0.14M | 0.0% | N/A | 0.018% | |
| 5/12/2021 | Northern Trust Corp | 40,246 | $0.51M | 0.0% | N/A | 0.068% | |
| 5/12/2021 | Geode Capital Management LLC | 220,355 | $2.82M | 0.0% | N/A | 0.370% | |
| 5/7/2021 | BlackRock Inc. | 54,217 | $0.69M | 0.0% | N/A | 0.091% | |
| 4/27/2021 | Harel Insurance Investments & Financial Services Ltd. | 34,911 | $1.49M | 0.0% | N/A | 1.010% | |
| 2/16/2021 | Walleye Trading LLC | 15,909 | $0.14M | 0.0% | N/A | 0.460% | |
| 2/12/2021 | Basso Capital Management L.P. | 3,239 | $29K | 0.0% | N/A | 0.094% | |
| 2/12/2021 | Kepos Capital LP | 263,235 | $2.37M | 0.2% | N/A | 7.617% | |
| 2/10/2021 | Bluefin Capital Management LLC | 15,378 | $0.14M | 0.0% | N/A | 0.445% | |
Data available starting January 2016
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean surfaced nanotechnology (CSN) therapeutics. The company has a nanotechnology drug suspension; and engages in the development and commercialization of dietary supplements. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2 study for the treatment of stable multiple sclerosis; a Phase 2 biomarker study in Parkinson's; and Phase 2 and Phase 3 trials to investigate the potential for disease modification for neurodegenerative diseases. The company's products also include CNM-AgZn17, a topical gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat disease-causing infections, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. Clene Inc. is headquartered in Salt Lake City, Utah.
Read More on Clene
Today's Range
Now: $10.79
52 Week Range
Now: $10.79
Volume
3,846 shs
Average Volume
191,982 shs
Market Capitalization
$642.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.06
Who are the company insiders with the largest holdings of Clene?
Clene's top insider shareholders include:
- David J Matlin (Director)
Who are the major institutional investors of Clene?
Clene's top institutional shareholders include:
- Laird Norton Trust Company LLC — 0.42%
- Geode Capital Management LLC — 0.37%
- Kepos Capital LP — 0.34%
- Millennium Management LLC — 0.22%
- Ikarian Capital LLC — 0.20%
- BlackRock Inc. — 0.09%
Which institutional investors are selling Clene stock?
Within the last quarter, CLNN stock was sold by these institutional investors:
- Kepos Capital LP
Which institutional investors are buying Clene stock?
During the last quarter, CLNN stock was acquired by institutional investors including:
- Laird Norton Trust Company LLC
- Geode Capital Management LLC
- Millennium Management LLC
- Ikarian Capital LLC
- BlackRock Inc.
- Citadel Advisors LLC
- Northern Trust Corp
- Harel Insurance Investments & Financial Services Ltd.
